Reporting Manager
Leonard Braden Michael
Symbol
IKNA
Shares outstanding
48,118,847 shares
Disclosed Ownership
4,090,102 shares
Ownership
8.5%
Form type
SCHEDULE 13D
Filing time
16 Jun 2025, 12:21:15 UTC
Date of event
16 Jun 2025
Previous filing
14 Feb 2025

Quoteable Key Fact

"BML Investment Partners, L.P. disclosed 8.5% ownership in Ikena Oncology, Inc. Common Stock, par value $0.001 per share (IKNA) on 16 Jun 2025."

Quick Takeaways

  • BML Investment Partners, L.P. filed SCHEDULE 13D for Ikena Oncology, Inc. Common Stock, par value $0.001 per share (IKNA).
  • Disclosed ownership: 8.5%.
  • Date of event: 16 Jun 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 16 Jun 2025, 12:21.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BML Investment Partners, L.P. 8.4% 4,030,102 0 4,030,102 Braden M Leonard BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member 0001373604
Leonard Braden Michael 8.5% 4,090,102 60,000 4,030,102 Braden M Leonard Leonard Braden Michael 0001373603
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .